Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Patti

Showing results (21-30 of 376) with videos related to

Pageof 38
Sort By:
Expert Review of Neurotherapeutics|February 25, 2015
Monoclonal antibody therapy in multiple sclerosis: critical appraisal and new perspectivesEmanuele D'Amico, Cinzia Caserta, Francesco Patti
Expert Opinion on Drug Safety|January 3, 2025
New strategies to manage the safety of cladribine in patients with multiple sclerosisPaola Reitano, Clara G Chisari, Francesco Patti
Expert Review of Neurotherapeutics|August 12, 2014
Fostering adherence to injectable disease-modifying therapies in multiple sclerosisAlessandra Lugaresi, Maria Rosa Rottoli, Francesco Patti
Children (Basel, Switzerland)|January 21, 2022
Paediatric Multiple Sclerosis: A Scoping Review of Patients' and Parents' PerspectivesMaria Luca, Nerea Ortega-Castro, Francesco Patti
Neurology and Therapy|October 9, 2021
Multiple Sclerosis, COVID-19 and Vaccines: Making the PointSimona Toscano, Clara G Chisari, Francesco Patti
Expert Review of Neurotherapeutics|October 11, 2016
Palliative care in progressive multiple sclerosisEmanuele D'Amico, Aurora Zanghì, Francesco Patti, et al.
International Journal of Environmental Research and Public Health|May 28, 2022
Stopping Interferon Beta 1b Does Not Influence the Risk of Disability Accrual in Non-Active SPMS: Results from an Italian Real-World StudyAurora Zanghì, Emanuele D'Amico, Francesco Patti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 28, 2016
Can we define a rehabilitation strategy for cognitive impairment in progressive multiple sclerosis? A critical appraisalEmanuele D'Amico, Carmela Leone, Tumani Hayrettin, et al.
Clinical Therapeutics|April 28, 2009
Drug rash with eosinophilia and systemic signs syndrome in a patient with multiple sclerosisAngelo Caruso, Rosario Vecchio, Francesco Patti, et al.
Journal of the Neurological Sciences|September 23, 2016
When the word doesn't come out: A synthetic overview of dysarthriaLiborio Rampello, Luigi Rampello, Francesco Patti, et al.
Pageof 38

Showing results (21-30 of 376) with videos related to

Sort By:
Pageof 38
Expert Review of Neurotherapeutics|February 25, 2015
Monoclonal antibody therapy in multiple sclerosis: critical appraisal and new perspectivesEmanuele D'Amico, Cinzia Caserta, Francesco Patti
Expert Opinion on Drug Safety|January 3, 2025
New strategies to manage the safety of cladribine in patients with multiple sclerosisPaola Reitano, Clara G Chisari, Francesco Patti
Expert Review of Neurotherapeutics|August 12, 2014
Fostering adherence to injectable disease-modifying therapies in multiple sclerosisAlessandra Lugaresi, Maria Rosa Rottoli, Francesco Patti
Children (Basel, Switzerland)|January 21, 2022
Paediatric Multiple Sclerosis: A Scoping Review of Patients' and Parents' PerspectivesMaria Luca, Nerea Ortega-Castro, Francesco Patti
Neurology and Therapy|October 9, 2021
Multiple Sclerosis, COVID-19 and Vaccines: Making the PointSimona Toscano, Clara G Chisari, Francesco Patti
Expert Review of Neurotherapeutics|October 11, 2016
Palliative care in progressive multiple sclerosisEmanuele D'Amico, Aurora Zanghì, Francesco Patti, et al.
International Journal of Environmental Research and Public Health|May 28, 2022
Stopping Interferon Beta 1b Does Not Influence the Risk of Disability Accrual in Non-Active SPMS: Results from an Italian Real-World StudyAurora Zanghì, Emanuele D'Amico, Francesco Patti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 28, 2016
Can we define a rehabilitation strategy for cognitive impairment in progressive multiple sclerosis? A critical appraisalEmanuele D'Amico, Carmela Leone, Tumani Hayrettin, et al.
Clinical Therapeutics|April 28, 2009
Drug rash with eosinophilia and systemic signs syndrome in a patient with multiple sclerosisAngelo Caruso, Rosario Vecchio, Francesco Patti, et al.
Journal of the Neurological Sciences|September 23, 2016
When the word doesn't come out: A synthetic overview of dysarthriaLiborio Rampello, Luigi Rampello, Francesco Patti, et al.
Pageof 38